Vera Health Quietly Became One of the World's Most Used Clinical Tools
Vera Health, providing evidence-based clinical answers, led by Maxime Allouch and Taieb Bennani, announced a $28.5 million Series A led by Threshold Ventures, with participation from Mantis VC and SV Angel. Existing investors Y Combinator and Gradient tripled down, bringing the company's total funding to $32 million.
Vera Health has grown from a few thousand users to more than 800,000 clinicians in a year, reaching healthcare professionals across 190 countries, largely through word of mouth. Since June, it has been the world’s most-downloaded clinical app across the App Store and Google Play each month. With a team of just 12 employees, Vera has reached approximately one in four physicians in Spain and Italy and one in seven in France.
“Clinicians are the best data scientists I’ve ever met. They make the call in seconds, with more evidence than any human could ever read,” said Taieb Bennani, co-founder of Vera Health. “The secret to building for them is to live and breathe the problem like no one else. Everyone on our team is a clinician, or the child or sibling of one, like Maxime and me. That passion translates into every detail of the product, and when you build with that kind of obsession, the product speaks for itself, and clinicians share it with their colleagues. We don't have the biggest team or the most money. We have the people who care the most about getting it right.”
How does Vera Health differ from general-purpose AI tools?
Unlike general-purpose chatbots designed to sound confident, Vera Health prioritizes accuracy and transparency. It searches more than 60 million peer-reviewed publications, clinical guidelines, consensus statements, and drug labels before generating answers. Every claim links to supporting research, with color-coded indicators showing the strength of the available evidence.
When evidence is limited, Vera makes those gaps visible. Research based on small case series or single-patient reports is surfaced alongside clear limitations, helping physicians judge the reliability of findings.
“Medical knowledge moves too quickly for any one clinician to read, and general-purpose AI tools can make uncertain evidence sound settled,” said Maxime Allouch, co-founder of Vera Health. “Unlike other tools, we believe there’s value in making uncertainty visible. The grade shapes what Vera retrieves and writes, while the clinician brings the patient, the context and the judgment.”
Through its partnership with the American College of Emergency Physicians (ACEP), the platform integrates ACEP clinical policies with source attribution.
“In medicine, not all evidence is equal,” said Scott M. Silvers, MD, FACEP, Chair of the American College of Emergency Physicians' Clinical Policies Committee and former Chair of Emergency Medicine at Mayo Clinic. “A large, randomized trial and a case report should never carry the same weight, yet most AI tools blend them into the same confident answer. Level of evidence is the foundation of every guideline we write, and Vera Health is built on it.”
“On a recent emergency-department shift, I saw a young woman with cough and shortness of breath. The symptoms could easily be attributed to a routine respiratory illness,” said Dr. Bernard P. Chang, Vera Health's Chief Scientific Advisor and Vice Chair of Research in the Department of Emergency Medicine at Columbia University. “Vera Health surfaced evidence that raised my concern for pulmonary embolism, a potentially life-threatening blood clot in the lungs, and led me to broaden my evaluation. What interests me isn’t AI simply providing an answer. It’s whether it can reliably surface evidence that challenges our initial assumptions and improves clinical reasoning. That’s what we’re now evaluating rigorously, inside the academic medical centers where medicine is actually practiced.”
Why is Vera Health growing so quickly across international markets?
Medical knowledge is global, but clinical practice is local, so Vera prioritizes locally relevant guidance while drawing on research worldwide.
“Medicine is global, yet most tools in our space were built for a single geography,” said Allouch. “We went international from day one, because only a global view reveals what is truly local.”
What will Vera Health's funding support next?
The funding will support further development of Vera Health’s clinical evidence infrastructure, expansion into new healthcare markets and deeper partnerships with medical societies, publishers and health systems. The platform will remain free for licensed clinicians and medical trainees worldwide.
Research published in the Journal of the Royal Society of Medicine estimates that new medical knowledge takes approximately 17 years to reach routine clinical practice.
“Our mission is to close the gap between what medicine knows and what every patient receives,” said Bennani. “Today, that gap is measured in years. We want it measured in seconds.”
